BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 25144244)

  • 21. Cellular turnover of the polyglutamine disease protein ataxin-3 is regulated by its catalytic activity.
    Todi SV; Laco MN; Winborn BJ; Travis SM; Wen HM; Paulson HL
    J Biol Chem; 2007 Oct; 282(40):29348-58. PubMed ID: 17693639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of Ataxin-3 and Ataxin-7 aggregates formed in vivo in Drosophila reveals a threshold of aggregated polyglutamine proteins associated with cellular toxicity.
    Vinatier G; Corsi JM; Mignotte B; Gaumer S
    Biochem Biophys Res Commun; 2015 Sep; 464(4):1060-1065. PubMed ID: 26210447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ubiquitination regulates the neuroprotective function of the deubiquitinase ataxin-3 in vivo.
    Tsou WL; Burr AA; Ouyang M; Blount JR; Scaglione KM; Todi SV
    J Biol Chem; 2013 Nov; 288(48):34460-9. PubMed ID: 24106274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polyglutamine tracts regulate beclin 1-dependent autophagy.
    Ashkenazi A; Bento CF; Ricketts T; Vicinanza M; Siddiqi F; Pavel M; Squitieri F; Hardenberg MC; Imarisio S; Menzies FM; Rubinsztein DC
    Nature; 2017 May; 545(7652):108-111. PubMed ID: 28445460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Components of the ubiquitin-proteasome pathway compete for surfaces on Rad23 family proteins.
    Goh AM; Walters KJ; Elsasser S; Verma R; Deshaies RJ; Finley D; Howley PM
    BMC Biochem; 2008 Jan; 9():4. PubMed ID: 18234089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide screen for modifiers of ataxin-3 neurodegeneration in Drosophila.
    Bilen J; Bonini NM
    PLoS Genet; 2007 Oct; 3(10):1950-64. PubMed ID: 17953484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ataxin-3, the MJD1 gene product, interacts with the two human homologs of yeast DNA repair protein RAD23, HHR23A and HHR23B.
    Wang G; Sawai N; Kotliarova S; Kanazawa I; Nukina N
    Hum Mol Genet; 2000 Jul; 9(12):1795-803. PubMed ID: 10915768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antisense oligonucleotide-mediated exon skipping as a strategy to reduce proteolytic cleavage of ataxin-3.
    Toonen LJ; Schmidt I; Luijsterburg MS; van Attikum H; van Roon-Mom WM
    Sci Rep; 2016 Oct; 6():35200. PubMed ID: 27731380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CHIP protects from the neurotoxicity of expanded and wild-type ataxin-1 and promotes their ubiquitination and degradation.
    Al-Ramahi I; Lam YC; Chen HK; de Gouyon B; Zhang M; Pérez AM; Branco J; de Haro M; Patterson C; Zoghbi HY; Botas J
    J Biol Chem; 2006 Sep; 281(36):26714-24. PubMed ID: 16831871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p45, an ATPase subunit of the 19S proteasome, targets the polyglutamine disease protein ataxin-3 to the proteasome.
    Wang H; Jia N; Fei E; Wang Z; Liu C; Zhang T; Fan J; Wu M; Chen L; Nukina N; Zhou J; Wang G
    J Neurochem; 2007 Jun; 101(6):1651-61. PubMed ID: 17302910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Valosin-containing protein (VCP/p97) is an activator of wild-type ataxin-3.
    Laço MN; Cortes L; Travis SM; Paulson HL; Rego AC
    PLoS One; 2012; 7(9):e43563. PubMed ID: 22970133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Praja1 ubiquitin ligase facilitates degradation of polyglutamine proteins and suppresses polyglutamine-mediated toxicity.
    Ghosh B; Karmakar S; Prasad M; Mandal AK
    Mol Biol Cell; 2021 Aug; 32(17):1579-1593. PubMed ID: 34161122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neurodegenerative diseases regulated by ubiquitin-proteasome system].
    Hatakeyama S
    Rinsho Shinkeigaku; 2006 Nov; 46(11):890-2. PubMed ID: 17432211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preventing Ataxin-3 protein cleavage mitigates degeneration in a Drosophila model of SCA3.
    Jung J; Xu K; Lessing D; Bonini NM
    Hum Mol Genet; 2009 Dec; 18(24):4843-52. PubMed ID: 19783548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FAT10 protein binds to polyglutamine proteins and modulates their solubility.
    Nagashima Y; Kowa H; Tsuji S; Iwata A
    J Biol Chem; 2011 Aug; 286(34):29594-600. PubMed ID: 21757738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteotoxic stress increases nuclear localization of ataxin-3.
    Reina CP; Zhong X; Pittman RN
    Hum Mol Genet; 2010 Jan; 19(2):235-49. PubMed ID: 19843543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The deubiquitylating enzyme Ubp12 regulates Rad23-dependent proteasomal degradation.
    Gödderz D; Giovannucci TA; Laláková J; Menéndez-Benito V; Dantuma NP
    J Cell Sci; 2017 Oct; 130(19):3336-3346. PubMed ID: 28966167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ataxin-3 consolidates the MDC1-dependent DNA double-strand break response by counteracting the SUMO-targeted ubiquitin ligase RNF4.
    Pfeiffer A; Luijsterburg MS; Acs K; Wiegant WW; Helfricht A; Herzog LK; Minoia M; Böttcher C; Salomons FA; van Attikum H; Dantuma NP
    EMBO J; 2017 Apr; 36(8):1066-1083. PubMed ID: 28275011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The BAG2 and BAG5 proteins inhibit the ubiquitination of pathogenic ataxin3-80Q.
    Che XQ; Tang BS; Wang HF; Yan XX; Jiang H; Shen L; Xu Q; Wang GH; Zhang HN; Wang CY; Guo JF
    Int J Neurosci; 2015 May; 125(5):390-4. PubMed ID: 25006867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lignin-carbohydrate complexes suppress SCA3 neurodegeneration via upregulating proteasomal activities.
    Chen ZS; Yan M; Pei W; Yan B; Huang C; Chan HYE
    Int J Biol Macromol; 2022 Oct; 218():690-705. PubMed ID: 35872311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.